Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
ISO 20857-19 (CSA ISO 20857:19): A Comprehensive Guide to Dry Heat Sterilization Standards
Understanding the Technical Requirements and Compliance Strategies for Sterilization of Health Care Products Using Dry Heat
Scope and Field of Application
ISO 20857-19, formally adopted as CSA ISO 20857:19 (the Canadian adoption of ISO 20857:2010), serves as the international benchmark for dry heat sterilization processes applied to medical devices. While moist heat (steam) sterilization is widely utilized, dry heat remains indispensable for processing items that are sensitive to moisture or impermeable to steam. This standard specifically covers the requirements for the development, validation, routine control, and monitoring of dry heat sterilization processes.
The standard applies to dry heat sterilization processes involving the exposure of medical devices to hot air or other dry heated gases. It encompasses a variety of equipment configurations, including batch ovens (gravity convection and mechanical convection) and continuous tunnels, which are commonly used for sterilization and depyrogenation of heat-stable materials such as glass, metal instruments, and anhydrous oils.
Tip: Dry heat sterilization is often the method of choice for anhydrous oils, powders, petroleum-based products, and sharp instruments made of stainless steel or glass that may dull or corrode in steam environments. This standard provides the framework for ensuring sterility while maintaining product integrity.
Crucially, this standard aligns with the general sterilization standards family (ISO 11135 for EtO, ISO 17665 for Moist Heat, ISO 11137 for Radiation) while addressing the unique physical characteristics of dry heat. A key differentiator is the reliance on high temperatures (typically 160 °C to 190 °C) and longer exposure times compared to steam sterilization, necessitating rigorous proof of thermal uniformity.
Technical Requirements for Process Development
The cornerstone of ISO 20857-19 is the rigorous definition of the sterilization process. The standard mandates that the manufacturer must define the Sterilization Process Definition prior to validation. This includes identifying the critical process parameters (CPPs) and establishing the maximum and minimum acceptable limits.
Key Process Parameters
The primary parameters for dry heat sterilization are temperature, time, and air distribution. Unlike steam, where condensation provides efficient heat transfer, dry heat relies on convection and radiation, requiring precise control of uniformity across the chamber.
| Parameter | Typical Requirement | Relevance to ISO 20857-19 |
|---|---|---|
| Temperature Range | 160 °C – 190 °C (sterilization) ≥ 250 °C (depyrogenation) | Must be uniform within ± 5 °C or tighter as defined during IQ/OQ. Cold spots must be identified and challenged. |
| Exposure Time | 30 – 120 minutes (temperature dependent) | Validated through heat penetration studies using thermocouples placed in the hardest-to-heat locations. |
| Biological Indicator (BI) | Bacillus atrophaeus (e.g., 10⁶ spores per carrier) | Resistance is characterized by D₁₂₁°C value; the standard requires D-value calculation at the specific sterilization temperature. |
| Air Velocity / Flow | HEPA filtered, unidirectional (tunnels) or controlled convection (batch) | Ensures uniform heat distribution and prevents stratification. Air flow direction and velocity must be mapped. |
Validation Requirements: IQ, OQ, PQ
ISO 20857-19 mandates a structured validation process aligned with ISO 14937 (General requirements for sterilization process characterization):- Installation Qualification (IQ): Verification that the sterilizer and supporting systems (heating elements, fans, HEPA filters, door interlocks) are installed correctly and adhere to engineering and design specifications.
- Operational Qualification (OQ): Functional testing of the equipment to demonstrate that it operates within defined limits. This includes chamber temperature distribution mapping under worst-case load conditions (both empty and fully loaded).
- Performance Qualification (PQ): Demonstrates that the defined process consistently yields a sterility assurance level (SAL) of 10⁻⁶. This involves biological indicator (BI) challenges placed at the hardest-to-sterilize locations identified during the OQ mapping studies.
Warning: A common non-compliance finding during audits involves the temperature uniformity criteria. Just because a single reference probe reaches the target temperature does not mean the entire load is sterile. ISO 20857-19 stresses the critical importance of identifying the cold spot within the chamber and load via thorough heat distribution and heat penetration studies.
Implementation Highlights and Routine Control
Once a process is validated, ISO 20857-19 requires strict adherence to the defined parameters during routine production. The standard emphasizes the concept of release of sterilized product and outlines distinct pathways for parametric release versus release based on biological indicator testing.
Cycle Monitoring
Routine cycles must be monitored against the validated parameters. This involves a combination of physical, chemical, and biological monitors:- Physical Monitors: Temperature recorders, pressure gauges, and air velocity sensors must provide continuous, calibrated data for the entire cycle duration.
- Chemical Indicators: Integrator or emulating indicators allow for immediate visual confirmation that a load has been exposed to the required process conditions.
- Biological Indicators: Routine BI testing is required for periodic verification of lethality. For parametric release systems, BI are used primarily during requalification or after significant changes.
Success Criteria: A robust dry heat validation utilizes the “Overkill” or “Bioburden” method. The standard allows for parametric release if the physical cycle parameters (time, temperature) are comprehensively monitored and validated against the biological response. This significantly reduces the need for final product sterility testing while maintaining a high SAL of 10⁻⁶.
Compliance Notes and Audit Considerations
Navigating an audit against ISO 20857-19 requires demonstrable evidence of control over the entire sterilization process lifecycle.
Documentation Trail
Auditors will look for a comprehensive Sterilization File. This file must demonstrate a clear chain of decision-making and include:- Process Definition: A formal rationale for selecting dry heat over other modalities, considering material compatibility and product function.
- Validation Protocol & Report: Detailed accounts of IQ, OQ, PQ with raw data traces, thermocouple maps, and BI results.
- Residual Risk Analysis: Assessment of potential hazards (e.g., material degradation, component embrittlement, label damage, pyrogen contamination).
- Change Control: Formal procedure governing any alteration to the cycle, equipment, software, or loading pattern. Significant changes require re-validation.
Risks to Avoid:
- Assuming a steam validation protocol applies directly to dry heat. Dry heat has significantly slower heat transfer rates and requires longer equilibration times.
- Neglecting to map the chamber under worst-case loading conditions, including variations in load density and composition.
- Failing to calibrate temperature probes directly against a certified reference standard that is traceable to a national metrology institute.
Special Considerations: Depyrogenation
While depyrogenation is not strictly classified as “sterilization” under this standard (since pyrogens are non-viable), many dry heat processes—particularly glassware tunnels in pharmaceutical filling lines—serve a dual purpose. ISO 20857-19 provides the validation and control framework directly applicable to these processes. Dry heat depyrogenation typically requires a minimum temperature of 250 °C to ensure endotoxin reduction by 3 log (10³). It is vital to clearly document the intended purpose of the cycle: sterilization, depyrogenation, or both, as the acceptance criteria differ.Frequently Asked Questions
Q: What is the key difference between ISO 20857-19 and ISO 17665 (Moist Heat)?
A: The primary difference lies in the medium of heat transfer. Moist heat (ISO 17665) relies on steam condensation and requires a saturated steam environment. Dry heat (ISO 20857) relies on hot air convection and radiation. Consequently, dry heat cycles require significantly higher temperatures (160 °C – 190 °C vs. 121 °C – 134 °C) and considerably longer exposure times due to the poorer heat transfer characteristics of air.
A: The primary difference lies in the medium of heat transfer. Moist heat (ISO 17665) relies on steam condensation and requires a saturated steam environment. Dry heat (ISO 20857) relies on hot air convection and radiation. Consequently, dry heat cycles require significantly higher temperatures (160 °C – 190 °C vs. 121 °C – 134 °C) and considerably longer exposure times due to the poorer heat transfer characteristics of air.
Q: Does ISO 20857-19 apply to depyrogenation tunnels?
A: Yes, while the primary scope is sterilization of health care products, the standard provides the validation and control framework that is directly applicable to dry heat depyrogenation processes. It defines requirements for temperature distribution, heat penetration, and microbial inactivation. Many practitioners explicitly reference the requirements of ISO 20857 to define their hot air tunnel validation protocols for pharmaceutical primary packaging.
A: Yes, while the primary scope is sterilization of health care products, the standard provides the validation and control framework that is directly applicable to dry heat depyrogenation processes. It defines requirements for temperature distribution, heat penetration, and microbial inactivation. Many practitioners explicitly reference the requirements of ISO 20857 to define their hot air tunnel validation protocols for pharmaceutical primary packaging.
Q: What are the most frequently audited elements of this standard?
A: Auditors consistently focus on three areas: (1) the temperature mapping data and identification of the cold spot, (2) the calibration and traceability of temperature sensors used during mapping and routine monitoring, and (3) the change control system governing process and load pattern modifications. A robust scientific rationale for the selected cycle lethality (F₀ or D-value) is also highly scrutinized.
A: Auditors consistently focus on three areas: (1) the temperature mapping data and identification of the cold spot, (2) the calibration and traceability of temperature sensors used during mapping and routine monitoring, and (3) the change control system governing process and load pattern modifications. A robust scientific rationale for the selected cycle lethality (F₀ or D-value) is also highly scrutinized.
Q: Is a biological indicator required for every production run under ISO 20857-19?
A: Not necessarily. The standard outlines conditions for parametric release. If the physical process parameters (temperature, time, air velocity) are continuously monitored, meet the validated limits, and the equipment is properly maintained, the batch can be released without routine biological indicator testing for every run. However, periodic BI verification and requalification (e.g., annually or after major maintenance) are mandatory to confirm ongoing process effectiveness.
A: Not necessarily. The standard outlines conditions for parametric release. If the physical process parameters (temperature, time, air velocity) are continuously monitored, meet the validated limits, and the equipment is properly maintained, the batch can be released without routine biological indicator testing for every run. However, periodic BI verification and requalification (e.g., annually or after major maintenance) are mandatory to confirm ongoing process effectiveness.
Reference: CSA ISO 20857:19, ISO 20857:2010. This article provides a technical overview for informational purposes and does not replace the official standard text. Year of Publication: 2026.